Biotechnology News REMICADE Search

| Biotechnology feed | All feeds

BioNews
Biotechnology, Pharmaceutical and Life Science News

Search Results

Documents 1-25 out of 131 found

Current Search: remicade: 131

Human Genome Sciences Names Scott Habig Vice President, Sales
- Human Genome Sciences, Inc.

(Nasdaq: HGSI) today announced that Scott Habig has joined the Company as Vice President, Sales, reporting to Kevin P.

McRaith, Vice President, Sales and Marketing, HGS.

Habig was most recently Vice President, Sales, at...

Pharma Live: Feb 3 2010 7:02AM
Matching: remicade

Find similar documents

Biomarker could help doctors tailor treatment for rheumatoid arthritis
The study, led by researchers at Hospital for Special Surgery in collaboration with rheumatologists at University of Southern California, appears in the February issue of the journal Arthritis & Rheumatism.'While our study was performed on a relatively...

Innovations Report: Feb 3 2010 5:33AM
Matching: remicade

Find similar documents

Research and Markets: The Biotech Company League Table: Fortunes of the Top 100 Biotech Companies Involved in Human Healthcare on the Basis of Product
45 AM DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/e308ab/the_biotech_compan) has announced the addition of the "The Biotech Company League Table" report to their offering.

The worlds first biotechnology company,...

Yahoo! Canada: Feb 2 2010 10:52PM
Matching: remicade

Find similar documents

Human Genome Sciences Names Scott Habig Vice President, Sales
ROCKVILLE, Md.--(HSMN NewsFeed)--Human Genome Sciences, Inc.

(Nasdaq: HGSI ) today announced that Scott Habig has joined the Company as Vice President, Sales, reporting to Kevin P.

McRaith, Vice President, Sales and Marketing, HGS.

Habig was most recently...

Healthcare Sales & Marketing Network: Feb 2 2010 10:04AM
Matching: remicade

Find similar documents

Human Genome Sciences Names Scott Habig Vice President, Sales
ROCKVILLE, Md.-- (BUSINESS WIRE) -- Human Genome Sciences, Inc.

(Nasdaq: HGSI) today announced that Scott Habig has joined the Company as Vice President, Sales, reporting to Kevin P.

McRaith, Vice President, Sales and Marketing, HGS.

Habig was most...

SmartBrief: Feb 1 2010 6:43PM
Matching: remicade

Find similar documents

Biomarker Could Help Doctors Tailor Treatment for Rheumatoid Arthritis
Investigators have identified a biomarker that could help doctors select patients with rheumatoid arthritis who will benefit from therapy with drugs such as Enbrel, a tumor necrosis factor (TNF)-antagonist drug.

The study, led by researchers at in...

Clinical Lab Products: Feb 1 2010 5:50PM
Matching: remicade

Find similar documents

Human Genome Sciences Names Scott Habig Vice President, Sales
BusinessWire - Human Genome Sciences, Inc.

(Nasdaq: HGSI) today announced that Scott Habig has joined the Company as Vice President, Sales, reporting to Kevin P.

McRaith, Vice President, Sales and Marketing, HGS.

Habig was most recently Vice President,...

Forbes.com: Feb 1 2010 1:13PM
Matching: remicade

Find similar documents

Human Genome Sciences Names Scott Habig Vice President, Sales
ROCKVILLE, Md.--(BUSINESS WIRE)--Human Genome Sciences, Inc.

(Nasdaq: HGSI) today announced that Scott Habig has joined the Company as Vice President, Sales, reporting to Kevin P.

McRaith, Vice President, Sales and Marketing, HGS.

Habig was most recently...

Yahoo! Canada: Feb 1 2010 1:01PM
Matching: remicade

Find similar documents

Human Genome Sciences Names Scott Habig Vice President, Sales
Human Genome Sciences, Inc.

(Nasdaq: HGSI) today announced that Scott Habig has joined the Company as Vice President, Sales, reporting to Kevin P.

McRaith, Vice President, Sales and Marketing, HGS.

Habig was most recently Vice President, Sales, at...

Genetic Engineering News: Feb 1 2010 12:56PM
Matching: remicade

Find similar documents

Human Genome Sciences Names Scott Habig Vice President, Sales
Companies mentioned in this article: Human Genome Sciences, Inc.

ROCKVILLE, Md.

-- (BUSINESS WIRE) -- Human Genome Sciences, Inc.

(Nasdaq: HGSI) today announced that Scott Habig has joined the Company as Vice President, Sales, reporting to Kevin P.

Freshnews.com: Feb 1 2010 12:54PM
Matching: remicade

Find similar documents

Human Genome Sciences Names Scott Habig Vice President, Sales
GA_googleFillSlot("Press336"); GA_googleFillSlot("Press160"); ROCKVILLE, Md.

- (Business Wire) Human Genome Sciences, Inc.

(Nasdaq: HGSI) today announced that Scott Habig has joined the Company as Vice President, Sales, reporting to Kevin P.

McRaith, Vice...

Earthtimes.org: Feb 1 2010 12:48PM
Matching: remicade

Find similar documents

Human Genome Sciences Names Scott Habig Vice President, Sales
GA_googleFillSlot("Press336"); GA_googleFillSlot("Press160"); ROCKVILLE, Md.

- (Business Wire) Human Genome Sciences, Inc.

(Nasdaq: HGSI) today announced that Scott Habig has joined the Company as Vice President, Sales, reporting to Kevin P.

McRaith, Vice...

Earthtimes.org: Feb 1 2010 12:47PM
Matching: remicade

Find similar documents

Human Genome Sciences Names Scott Habig Vice President, Sales
Human Genome Sciences, Inc.

(Nasdaq: HGSI) today announced that Scott Habig has joined the Company as Vice President, Sales, reporting to Kevin P.

McRaith, Vice President, Sales and Marketing, HGS.

Habig was most recently Vice President, Sales, at...

PR inside: Feb 1 2010 12:29PM
Matching: remicade

Find similar documents

Human Genome Sciences Names Scott Habig Vice President, Sales
ROCKVILLE, Md.Human Genome Sciences, Inc.

(Nasdaq Scott Habig is exemplary of the top leadership talent with which we are building up our commercial organization.

He brings to HGS more than 25 years of experience as a leader in the sales and marketing of...

Business Wire via Yahoo!: Feb 1 2010 12:28PM
Matching: remicade

Find similar documents

Human Genome Sciences Names Scott Habig Vice President, Sales
{"s" : "hgsi","k" : "c10,l10,p20,t10","o" : "","j" : ""} Press Release Source: Human Genome Sciences, Inc.

On Monday February 1, 2010, 7:00 am ROCKVILLE, Md.--(BUSINESS WIRE)--Human Genome Sciences, Inc.

(Nasdaq: HGSI - News) today announced that Scott...

Business Wire via Yahoo!: Feb 1 2010 12:27PM
Matching: remicade

Find similar documents

Human Genome Sciences Names Scott Habig Vice President, Sales
ROCKVILLE, Md.

- (BUSINESS WIRE) - Human Genome Sciences, Inc.

(Nasdaq: HGSI) today announced that Scott Habig has joined the Company as Vice President, Sales, reporting to Kevin P.

McRaith, Vice President, Sales and Marketing, HGS.

Habig was most...

NewsBlaze: Feb 1 2010 12:18PM
Matching: remicade

Find similar documents

Human Genome Sciences Names Scott Habig Vice President, Sales
Human Genome Sciences, Inc.

(Nasdaq: HGSI) today announced that Scott Habig has joined the Company as Vice President, Sales, reporting to Kevin P.

McRaith, Vice President, Sales and Marketing, HGS.

Habig was most recently Vice President, Sales, at...

FinanzNachrichten.de: Feb 1 2010 12:18PM
Matching: remicade

Find similar documents

Global Pharmaceutical Biotech Market 2010-2025 - New Market Report Published
The global pharmaceutical biotech market continues to experience high growth, with developers ranging from major pharmaceutical companies to specialist pharmaceutical firms.

Significant R&D efforts and innovative new treatments will lead to further...

OfficialWire: Jan 31 2010 12:40PM
Matching: remicade

Find similar documents

Biomarker Could Help Doctors Tailor Treatment For Rheumatoid Arthritis
Investigators have identified a biomarker that could help doctors select patients with rheumatoid arthritis who will benefit from therapy with drugs such as Enbrel, a tumor necrosis factor (TNF)-antagonist drug.

The study, led by researchers at Hospital for...

Medical News Today: Jan 31 2010 12:27PM
Matching: remicade

Find similar documents

Biomarker could help doctors tailor treatment for rheumatoid arthritis
Investigators have identified a biomarker that could help doctors select patients with rheumatoid arthritis who will benefit from therapy with drugs such as Enbrel, a tumour necrosis factor (TNF)-antagonist drug.

The study, led by researchers at in...

Science Centric: Jan 31 2010 2:41AM
Matching: remicade

Find similar documents

Global Pharmaceutical Biotech Market 2010-2025
The global pharmaceutical biotech market continues to experience high growth, with developers ranging from major pharmaceutical companies to specialist pharmaceutical firms.

Significant R&D efforts and innovative new treatments will lead to further...

PR-USA.net: Jan 30 2010 10:32PM
Matching: remicade

Find similar documents

Significant R&D efforts and innovative new treatments will lead to further...

PR inside: Jan 30 2010 6:57AM
Matching: remicade

Find similar documents

Global Pharmaceutical Biotech Market 2010-2025 by Bharatbook
Bharatbook.com added a new report on "Global Pharmaceutical Biotech Market 2010-2025" which gives Comprehensive analysis of the global biopharma market.

FOR IMMEDIATE RELEASE PR Log (Press Release) Jan 30, 2010 Global Pharmaceutical Biotech Market 2010-2025...

PRLog: Jan 30 2010 6:56AM
Matching: remicade

Find similar documents

New biomarker may predict treatment outcomes in RA patients
Investigators have identified a biomarker that could help doctors select patients with rheumatoid arthritis who will benefit from therapy with drugs such as Enbrel, a tumor necrosis factor (TNF)-antagonist drug.

The study, led by researchers at Hospital for...

News-Medical.Net: Jan 30 2010 6:18AM
Matching: remicade

Find similar documents

Biomarker could help doctors tailor treatment for rheumatoid arthritis
ScienceDaily (Jan.

29, 2010) Investigators have identified a biomarker that could help doctors select patients with rheumatoid arthritis who will benefit from therapy with drugs such as Enbrel, a tumor necrosis factor (TNF)-antagonist drug.

The study, led...

Science Daily: Jan 29 2010 6:19PM
Matching: remicade

Find similar documents

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.